Kenvue Inc. $KVUE Stake Boosted by Voya Investment Management LLC

Voya Investment Management LLC increased its position in shares of Kenvue Inc. (NYSE:KVUE) by 131.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 12,131,468 shares of the company’s stock after purchasing an additional 6,886,784 shares during the period. Voya Investment Management LLC’s holdings in Kenvue were worth $290,557,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently added to or reduced their stakes in the stock. Modern Wealth Management LLC lifted its stake in Kenvue by 27.8% in the first quarter. Modern Wealth Management LLC now owns 13,669 shares of the company’s stock valued at $328,000 after buying an additional 2,975 shares during the last quarter. Strs Ohio acquired a new position in shares of Kenvue during the first quarter valued at $57,364,000. Intrua Financial LLC increased its holdings in shares of Kenvue by 37.3% during the first quarter. Intrua Financial LLC now owns 27,181 shares of the company’s stock valued at $652,000 after purchasing an additional 7,386 shares during the period. Advisors Capital Management LLC increased its holdings in shares of Kenvue by 64.1% during the first quarter. Advisors Capital Management LLC now owns 1,529,161 shares of the company’s stock valued at $36,669,000 after purchasing an additional 597,396 shares during the period. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Kenvue by 384.1% during the first quarter. Geneos Wealth Management Inc. now owns 6,632 shares of the company’s stock valued at $159,000 after purchasing an additional 5,262 shares during the period. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

KVUE has been the topic of a number of research analyst reports. Citigroup lowered their target price on Kenvue from $24.50 to $22.00 and set a “neutral” rating on the stock in a report on Tuesday, July 15th. Barclays lowered their target price on Kenvue from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, July 15th. JPMorgan Chase & Co. lowered their target price on Kenvue from $27.00 to $26.00 and set an “overweight” rating on the stock in a report on Friday, July 25th. Canaccord Genuity Group lowered their target price on Kenvue from $29.00 to $26.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Finally, UBS Group lowered their target price on Kenvue from $25.00 to $23.00 and set a “neutral” rating on the stock in a report on Thursday, July 17th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and an average target price of $24.21.

Kenvue Trading Up 2.0%

Shares of KVUE opened at $18.84 on Friday. The business’s 50-day moving average price is $21.18 and its 200 day moving average price is $22.27. The stock has a market capitalization of $36.16 billion, a P/E ratio of 25.46, a P/E/G ratio of 2.65 and a beta of 0.83. Kenvue Inc. has a 1-year low of $17.15 and a 1-year high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The firm had revenue of $3.84 billion for the quarter, compared to analysts’ expectations of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue’s revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the business posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a $0.2075 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s dividend payout ratio (DPR) is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.